Enanta Pharmaceuticals Inc (ENTA)
R&D Expenses
$22.13M
Quarterly · Period ending: · USD
ENTA R&D Expenses
Latest reported$22.13Mperiod ending
Latest reported$22.13Mperiod ending
ENTA Quarterly R&D Expenses ($2.93M → $22.13M)
Quarterly R&D Expenses
High-resolution chart · PNG
ENTA r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 22,126,000 | |
| 19,443,000 | |
| 20,859,000 | |
| 23,809,000 | |
| 27,210,000 | |
| 28,065,000 | |
| 27,656,000 | |
| 30,778,000 | |
| 28,742,000 | |
| 35,585,000 | |
| 36,371,000 | |
| 36,167,000 | |
| 42,987,000 | |
| 43,468,000 | |
| 40,902,000 | |
| 34,796,000 | |
| 39,090,000 | |
| 42,087,000 | |
| 48,549,000 | |
| 48,946,000 | |
| 46,994,000 | |
| 41,506,000 | |
| 36,665,000 | |
| 36,686,000 | |
| 34,682,000 | |
| 32,610,000 | |
| 32,778,000 | |
| 38,719,000 | |
| 34,461,000 | |
| 34,155,000 | |
| 34,878,000 | |
| 26,923,000 | |
| 28,487,000 | |
| 21,484,000 | |
| 17,962,000 | |
| 16,514,000 | |
| 15,407,000 | |
| 13,004,000 | |
| 12,526,000 | |
| 11,500,000 | |
| 10,785,000 | |
| 9,143,000 | |
| 9,033,000 | |
| 7,049,000 | |
| 6,253,000 | |
| 5,368,000 | |
| 4,519,000 | |
| 5,202,000 | |
| 4,553,000 | |
| 4,722,000 | |
| 4,263,000 | |
| 4,300,000 | |
| 4,039,000 | |
| 3,855,000 | |
| 4,798,000 | |
| 4,255,000 | |
| 4,925,000 | |
| 3,263,000 | |
| 2,672,000 | |
| 2,929,000 |